| Product NDC: | 53808-0447 |
| Proprietary Name: | Levothyroxine Sodium |
| Non Proprietary Name: | Levothyroxine Sodium |
| Active Ingredient(s): | .075 mg/1 & nbsp; Levothyroxine Sodium |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 53808-0447 |
| Labeler Name: | State of Florida DOH Central Pharmacy |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021210 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20090701 |
| Package NDC: | 53808-0447-1 |
| Package Description: | 30 TABLET in 1 BLISTER PACK (53808-0447-1) |
| NDC Code | 53808-0447-1 |
| Proprietary Name | Levothyroxine Sodium |
| Package Description | 30 TABLET in 1 BLISTER PACK (53808-0447-1) |
| Product NDC | 53808-0447 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Levothyroxine Sodium |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20090701 |
| Marketing Category Name | NDA |
| Labeler Name | State of Florida DOH Central Pharmacy |
| Substance Name | LEVOTHYROXINE SODIUM |
| Strength Number | .075 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | l-Thyroxine [EPC],Thyroxine [Chemical/Ingredient] |